J.P. Sculier

2.8k total citations · 1 hit paper
54 papers, 1.4k citations indexed

About

J.P. Sculier is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, J.P. Sculier has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in J.P. Sculier's work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (20 papers) and Lung Cancer Diagnosis and Treatment (15 papers). J.P. Sculier is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (20 papers) and Lung Cancer Diagnosis and Treatment (15 papers). J.P. Sculier collaborates with scholars based in Belgium, France and Canada. J.P. Sculier's co-authors include Marianne Paesmans, Jan P. van Meerbeeck, Kari Chansky, John J. Crowley, Dori Giroux, Peter Goldstraw, T. Berghmans, A.-P. Meert, Céline Mascaux and Thierry Berghmans and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

J.P. Sculier

48 papers receiving 1.4k citations

Hit Papers

The International Association for the Study of Lung Cance... 2009 2026 2014 2020 2009 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Sculier Belgium 18 785 461 192 167 137 54 1.4k
Marine Castaing Italy 19 712 0.9× 793 1.7× 145 0.8× 177 1.1× 547 4.0× 43 1.9k
Lena Damber Sweden 27 748 1.0× 831 1.8× 202 1.1× 515 3.1× 503 3.7× 60 2.5k
Adele Seniori Costantini Italy 25 473 0.6× 532 1.2× 184 1.0× 113 0.7× 98 0.7× 80 2.1k
A Andersen Norway 28 586 0.7× 453 1.0× 150 0.8× 168 1.0× 240 1.8× 51 2.1k
Robert H. Lyles United States 19 568 0.7× 247 0.5× 133 0.7× 95 0.6× 399 2.9× 39 1.6k
Qingyuan Huang China 20 658 0.8× 286 0.6× 202 1.1× 111 0.7× 306 2.2× 55 1.1k
M. Usel Switzerland 19 390 0.5× 391 0.8× 86 0.4× 81 0.5× 158 1.2× 36 1.2k
John J. Spinelli Canada 17 260 0.3× 956 2.1× 190 1.0× 107 0.6× 88 0.6× 25 2.2k
G Leverger France 23 488 0.6× 365 0.8× 438 2.3× 111 0.7× 140 1.0× 77 1.9k

Countries citing papers authored by J.P. Sculier

Since Specialization
Citations

This map shows the geographic impact of J.P. Sculier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Sculier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Sculier more than expected).

Fields of papers citing papers by J.P. Sculier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Sculier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Sculier. The network helps show where J.P. Sculier may publish in the future.

Co-authorship network of co-authors of J.P. Sculier

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Sculier. A scholar is included among the top collaborators of J.P. Sculier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Sculier. J.P. Sculier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ameye, Lieveke, et al.. (2019). Cancer bronchique : le pronostic en soins intensifs dépendrait surtout de la complication. Revue des Maladies Respiratoires. 36(3). 333–341. 1 indexed citations
2.
Sigsgaard, Torben, Bertil Forsberg, Isabella Annesi‐Maesano, et al.. (2015). Health impacts of anthropogenic biomass burning in the developed world. European Respiratory Journal. 46(6). 1577–1588. 187 indexed citations
3.
Houtte, P. Van, Jean Klášterský, A. Renaud, et al.. (2015). Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiation Therapy for Nonsmall-Cell Lung Cancer. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 41. 131–137.
4.
Sculier, J.P., et al.. (2014). Updates in oncology. European Respiratory Review. 23(131). 69–78. 3 indexed citations
5.
Gaga, Mina, Charles A. Powell, Dean E. Schraufnagel, et al.. (2013). An Official American Thoracic Society/European Respiratory Society Statement: The Role of the Pulmonologist in the Diagnosis and Management of Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 188(4). 503–507. 43 indexed citations
6.
Berchier, M.C., Thierry Berghmans, Benoît Colinet, et al.. (2007). European Lung Cancer Working Party Clinical Practice Guidelines. Small Cell Lung Cnacer: IV. Limited disease. 2(2). 74–82. 1 indexed citations
7.
Berghmans, T., M. Paesmans, Céline Mascaux, et al.. (2006). Thyroid transcription factor 1—a new prognostic factor in lung cancer: a meta-analysis. Annals of Oncology. 17(11). 1673–1676. 111 indexed citations
8.
Berghmans, T., J.J. Lafitte, Marianne Paesmans, et al.. (2005). A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma. Lung Cancer. 50(1). 75–82. 22 indexed citations
9.
10.
Mascaux, C., et al.. (2003). Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53. European Respiratory Journal. 21(5). 753–758. 18 indexed citations
11.
Saunders, Margaret, J.P. Sculier, Peter Goldstraw, et al.. (2003). Consensus: the follow-up of the treated patient. Lung Cancer. 42(2). 17–19. 10 indexed citations
12.
Berghmans, T., A.-P. Meert, Céline Mascaux, et al.. (2003). Citation indexes do not reflect methodological quality in lung cancer randomised trials. Annals of Oncology. 14(5). 715–721. 32 indexed citations
13.
Sculier, J.P., J.J. Lafitte, T. Berghmans, et al.. (2000). A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. Lung Cancer. 29(1). 67–73. 41 indexed citations
14.
Sculier, J.P., Marianne Paesmans, J Thiriaux, et al.. (1999). A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Journal of Cancer. 35(9). 1314–1319. 20 indexed citations
15.
Sculier, J.P., Vincent Ninane, Anna Efremidis, et al.. (1999). The First World Conference on Clinical Cooperative Research for Lung Cancer, Brussels 4–6 March 1999☆. Lung Cancer. 26(2). 113–116.
16.
Sculier, J.P.. (1998). Should maintenance chemotherapy be used to treat small cell lung cancer? Pro:. European Journal of Cancer. 34(8). 1148–1151. 4 indexed citations
17.
Sculier, J.P.. (1995). Indications for intensive care in the management of infections in cancer patients. Cancer treatment and research. 79. 233–244. 1 indexed citations
18.
Sculier, J.P., Dominique Bron, A. Coune, & F. Meunier. (1989). Successful treatment with liposomal amphotericin B in two patients with persisting fungemia. European Journal of Clinical Microbiology & Infectious Diseases. 8(10). 903–907. 17 indexed citations
19.
Urbanski, Stefan J., A E Kossakowska, J. Randall Curtis, et al.. (1987). Idiopathic Small Airways Pathology in Patients with Graft-versus-Host Disease Following Allogeneic Bone Marrow Transplantation. The American Journal of Surgical Pathology. 11(12). 965–971. 45 indexed citations
20.
Ries, F., J.P. Sculier, & Jean Klášterský. (1987). Diffuse bilateral pneumopathies in patients with cancer. Cancer Treatment Reviews. 14(2). 119–130. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026